[{"edinetCode":"E05301","endDate":"2016\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":55.0,"averageTemporaryStaff":9.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5808202.0,"sharesOwendPercent":0.0822,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":54.65,"equityRatio":0.85,"cashAndCashEquivalents":995620000.0,"assets":4539201000.0,"currentAssets":3619461000.0,"fixedAsset":919739000.0,"tangibleFixedAssets":75902000.0,"intangibleFixedAssets":55155000.0,"investmentAndOtherAssets":788682000.0,"liabilities":669819000.0,"currentLiabilities":630917000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":38902000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":3869382000.0,"capitalStock":4265354000.0,"capital":17651190000.0,"capitalSurplus":15961930000.0,"accumulatedEarnings":-29347742000.0,"treasuryStock":-23000.0,"valuationAndConversionAdjustments":-405295000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":174511000.0,"grossProfit":null,"sgaExpenses":914588000.0,"salaryAndBenefit":147868000.0,"depreciationAndSGA":8537000.0,"RDExpenses":4188510000.0,"operatingIncome":-4763341000.0,"nonOperatingIncome":8933000.0,"nonOperatingExpenses":92889000.0,"interestExpense":null,"ordinaryProfit":-4847297000.0,"extraordinaryGain":86627000.0,"extraordinaryLoss":null,"incomeBeforeTax":-4760670000.0,"incomeTaxes":16110000.0,"netIncome":-4776780000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-4776780000.0,"comprehensiveIncome":-5182343000.0,"eps":-75.29,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-4983694000.0,"depreciationAndCashflowFromOperatingActivities":67306000.0,"cashFlowFromInvestingActivities":-829815000.0,"cashFlowFromFinancialActivities":4793388000.0,"changesInCashAndCashEquivalents":-1073204000.0,"列1":"asr","submitDate":"2017\/3\/31","stockCode":4563,"accountingYear":"第18期(自? 平成28年１月１日? 至? 平成28年12月31日)","accountingYearStart":"2016\/1\/1","accountingYearEnd":"2016\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2017\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":48.0,"averageTemporaryStaff":8.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6583596.0,"sharesOwendPercent":0.0826,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":42.29,"equityRatio":0.851,"cashAndCashEquivalents":1147753000.0,"assets":3963609000.0,"currentAssets":3433602000.0,"fixedAsset":530006000.0,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":530006000.0,"liabilities":341727000.0,"currentLiabilities":317561000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":24166000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":3621881000.0,"capitalStock":3446597000.0,"capital":5658349000.0,"capitalSurplus":1472971000.0,"accumulatedEarnings":-3684699000.0,"treasuryStock":-24000.0,"valuationAndConversionAdjustments":-74846000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":178049000.0,"grossProfit":null,"sgaExpenses":875708000.0,"salaryAndBenefit":139787000.0,"depreciationAndSGA":3339000.0,"RDExpenses":2600107000.0,"operatingIncome":-3288683000.0,"nonOperatingIncome":10235000.0,"nonOperatingExpenses":28691000.0,"interestExpense":null,"ordinaryProfit":-3307139000.0,"extraordinaryGain":152223000.0,"extraordinaryLoss":589271000.0,"incomeBeforeTax":-3744187000.0,"incomeTaxes":20512000.0,"netIncome":-3764699000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-3764699000.0,"comprehensiveIncome":-3434251000.0,"eps":-49.38,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2991223000.0,"depreciationAndCashflowFromOperatingActivities":29352000.0,"cashFlowFromInvestingActivities":227062000.0,"cashFlowFromFinancialActivities":2916035000.0,"changesInCashAndCashEquivalents":152133000.0,"列1":"asr","submitDate":"2018\/3\/30","stockCode":4563,"accountingYear":"第19期(自? 平成29年１月１日? 至? 平成29年12月31日)","accountingYearStart":"2017\/1\/1","accountingYearEnd":"2017\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":36.0,"averageTemporaryStaff":5.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6399810.0,"sharesOwendPercent":0.0653,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":78.38,"equityRatio":0.954,"cashAndCashEquivalents":5784894000.0,"assets":8050672000.0,"currentAssets":7542170000.0,"fixedAsset":508502000.0,"tangibleFixedAssets":47429000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":461072000.0,"liabilities":316213000.0,"currentLiabilities":291631000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":24581000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7734459000.0,"capitalStock":7924919000.0,"capital":9395825000.0,"capitalSurplus":5210447000.0,"accumulatedEarnings":-6681328000.0,"treasuryStock":-24000.0,"valuationAndConversionAdjustments":-244750000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":188176000.0,"grossProfit":null,"sgaExpenses":947454000.0,"salaryAndBenefit":127282000.0,"depreciationAndSGA":3003000.0,"RDExpenses":2539674000.0,"operatingIncome":-3065255000.0,"nonOperatingIncome":14176000.0,"nonOperatingExpenses":45135000.0,"interestExpense":null,"ordinaryProfit":-3096213000.0,"extraordinaryGain":93211000.0,"extraordinaryLoss":null,"incomeBeforeTax":-3003002000.0,"incomeTaxes":-6372000.0,"netIncome":-2996629000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-2996629000.0,"comprehensiveIncome":-3166532000.0,"eps":-34.46,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2522501000.0,"depreciationAndCashflowFromOperatingActivities":7860000.0,"cashFlowFromInvestingActivities":-122742000.0,"cashFlowFromFinancialActivities":7283345000.0,"changesInCashAndCashEquivalents":4637140000.0,"列1":"asr","submitDate":"2019\/3\/29","stockCode":4563,"accountingYear":"第20期(自? 2018年１月１日? 至? 2018年12月31日)","accountingYearStart":"2018\/1\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.975,"cashAndCashEquivalents":null,"assets":11935286000.0,"currentAssets":10743574000.0,"fixedAsset":1191712000.0,"tangibleFixedAssets":51844000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":1139867000.0,"liabilities":256584000.0,"currentLiabilities":229866000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":26717000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":11678702000.0,"capitalStock":11631459000.0,"capital":11841039000.0,"capitalSurplus":7655660000.0,"accumulatedEarnings":-7865214000.0,"treasuryStock":-25000.0,"valuationAndConversionAdjustments":6179000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":35974000.0,"grossProfit":null,"sgaExpenses":264180000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":693783000.0,"operatingIncome":-918380000.0,"nonOperatingIncome":4830000.0,"nonOperatingExpenses":24937000.0,"interestExpense":null,"ordinaryProfit":-938487000.0,"extraordinaryGain":null,"extraordinaryLoss":243123000.0,"incomeBeforeTax":-1181610000.0,"incomeTaxes":2275000.0,"netIncome":-1183886000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1183886000.0,"comprehensiveIncome":-932956000.0,"eps":-11.92,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/13","stockCode":4563,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":7512400.0,"sharesOwendPercent":0.0702,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.977,"cashAndCashEquivalents":11291204000.0,"assets":13922283000.0,"currentAssets":12409979000.0,"fixedAsset":1512304000.0,"tangibleFixedAssets":50733000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":1461571000.0,"liabilities":245063000.0,"currentLiabilities":219377000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":25686000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":13677220000.0,"capitalStock":13708799000.0,"capital":13274669000.0,"capitalSurplus":9089290000.0,"accumulatedEarnings":-8655135000.0,"treasuryStock":-25000.0,"valuationAndConversionAdjustments":-112713000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":83746000.0,"grossProfit":null,"sgaExpenses":668230000.0,"salaryAndBenefit":71422000.0,"depreciationAndSGA":1987000.0,"RDExpenses":1130185000.0,"operatingIncome":-1709576000.0,"nonOperatingIncome":14384000.0,"nonOperatingExpenses":38529000.0,"interestExpense":null,"ordinaryProfit":-1733720000.0,"extraordinaryGain":8288000.0,"extraordinaryLoss":243123000.0,"incomeBeforeTax":-1968556000.0,"incomeTaxes":5249000.0,"netIncome":-1973806000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1973806000.0,"comprehensiveIncome":-1841769000.0,"eps":-19.26,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1067175000.0,"depreciationAndCashflowFromOperatingActivities":3889000.0,"cashFlowFromInvestingActivities":-1110388000.0,"cashFlowFromFinancialActivities":7683345000.0,"changesInCashAndCashEquivalents":5506309000.0,"列1":"q2r","submitDate":"2019\/8\/9","stockCode":4563,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.967,"cashAndCashEquivalents":null,"assets":13360158000.0,"currentAssets":11903107000.0,"fixedAsset":1457050000.0,"tangibleFixedAssets":50569000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":1406481000.0,"liabilities":367583000.0,"currentLiabilities":341849000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":25733000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12992575000.0,"capitalStock":12944032000.0,"capital":13291912000.0,"capitalSurplus":9106534000.0,"accumulatedEarnings":-9454388000.0,"treasuryStock":-25000.0,"valuationAndConversionAdjustments":-22425000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":84897000.0,"grossProfit":null,"sgaExpenses":1010170000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1587470000.0,"operatingIncome":-2358558000.0,"nonOperatingIncome":17857000.0,"nonOperatingExpenses":44838000.0,"interestExpense":null,"ordinaryProfit":-2385539000.0,"extraordinaryGain":8288000.0,"extraordinaryLoss":384965000.0,"incomeBeforeTax":-2762217000.0,"incomeTaxes":8497000.0,"netIncome":-2770714000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-2770714000.0,"comprehensiveIncome":-2548388000.0,"eps":-26.65,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/8","stockCode":4563,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":36.0,"averageTemporaryStaff":2.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":8877262.0,"sharesOwendPercent":0.0829,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":111.83,"equityRatio":0.955,"cashAndCashEquivalents":10040595000.0,"assets":12524600000.0,"currentAssets":10992191000.0,"fixedAsset":1532408000.0,"tangibleFixedAssets":49441000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":1482966000.0,"liabilities":469248000.0,"currentLiabilities":443033000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":26215000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":12055351000.0,"capitalStock":11963919000.0,"capital":13291912000.0,"capitalSurplus":9106534000.0,"accumulatedEarnings":-10434498000.0,"treasuryStock":-30000.0,"valuationAndConversionAdjustments":-1488000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":87199000.0,"grossProfit":null,"sgaExpenses":1294489000.0,"salaryAndBenefit":146923000.0,"depreciationAndSGA":3975000.0,"RDExpenses":2215076000.0,"operatingIncome":-3270005000.0,"nonOperatingIncome":21711000.0,"nonOperatingExpenses":44921000.0,"interestExpense":null,"ordinaryProfit":-3293214000.0,"extraordinaryGain":10610000.0,"extraordinaryLoss":468999000.0,"incomeBeforeTax":-3751604000.0,"incomeTaxes":-780000.0,"netIncome":-3750823000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-3750823000.0,"comprehensiveIncome":-3507561000.0,"eps":-35.81,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2179918000.0,"depreciationAndCashflowFromOperatingActivities":7318000.0,"cashFlowFromInvestingActivities":-1249757000.0,"cashFlowFromFinancialActivities":7676981000.0,"changesInCashAndCashEquivalents":4255701000.0,"列1":"asr","submitDate":"2020\/3\/30","stockCode":4563,"accountingYear":"第21期(自? 2019年１月１日? 至? 2019年12月31日)","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.968,"cashAndCashEquivalents":null,"assets":14599990000.0,"currentAssets":10271566000.0,"fixedAsset":4328424000.0,"tangibleFixedAssets":48294000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":4280129000.0,"liabilities":329838000.0,"currentLiabilities":303828000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":26010000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":14270151000.0,"capitalStock":14136845000.0,"capital":14838360000.0,"capitalSurplus":10652982000.0,"accumulatedEarnings":-11354467000.0,"treasuryStock":-30000.0,"valuationAndConversionAdjustments":-8020000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":3453000.0,"grossProfit":null,"sgaExpenses":348075000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":628354000.0,"operatingIncome":-974150000.0,"nonOperatingIncome":73442000.0,"nonOperatingExpenses":22182000.0,"interestExpense":null,"ordinaryProfit":-922890000.0,"extraordinaryGain":5418000.0,"extraordinaryLoss":null,"incomeBeforeTax":-917472000.0,"incomeTaxes":2496000.0,"netIncome":-919969000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-919969000.0,"comprehensiveIncome":-926501000.0,"eps":-8.56,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/5\/13","stockCode":4563,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":10391768.0,"sharesOwendPercent":0.0844,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.974,"cashAndCashEquivalents":13552647000.0,"assets":22099031000.0,"currentAssets":15200903000.0,"fixedAsset":6898127000.0,"tangibleFixedAssets":47247000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":6850880000.0,"liabilities":437030000.0,"currentLiabilities":410982000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":26047000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":21662001000.0,"capitalStock":21557275000.0,"capital":19036593000.0,"capitalSurplus":14851215000.0,"accumulatedEarnings":-12330503000.0,"treasuryStock":-30000.0,"valuationAndConversionAdjustments":-42442000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":9208000.0,"grossProfit":null,"sgaExpenses":668964000.0,"salaryAndBenefit":80393000.0,"depreciationAndSGA":1939000.0,"RDExpenses":1104844000.0,"operatingIncome":-1766173000.0,"nonOperatingIncome":50145000.0,"nonOperatingExpenses":180192000.0,"interestExpense":null,"ordinaryProfit":-1896220000.0,"extraordinaryGain":5418000.0,"extraordinaryLoss":null,"incomeBeforeTax":-1890802000.0,"incomeTaxes":5202000.0,"netIncome":-1896004000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1896004000.0,"comprehensiveIncome":-1936958000.0,"eps":-16.58,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2412418000.0,"depreciationAndCashflowFromOperatingActivities":2842000.0,"cashFlowFromInvestingActivities":-5525502000.0,"cashFlowFromFinancialActivities":11414875000.0,"changesInCashAndCashEquivalents":3512051000.0,"列1":"q2r","submitDate":"2020\/8\/12","stockCode":4563,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.946,"cashAndCashEquivalents":null,"assets":21368216000.0,"currentAssets":14662228000.0,"fixedAsset":6705988000.0,"tangibleFixedAssets":46149000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":6659839000.0,"liabilities":1017395000.0,"currentLiabilities":991291000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":26104000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":20350821000.0,"capitalStock":20281650000.0,"capital":19038143000.0,"capitalSurplus":14852765000.0,"accumulatedEarnings":-13609228000.0,"treasuryStock":-30000.0,"valuationAndConversionAdjustments":-74901000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":16114000.0,"grossProfit":null,"sgaExpenses":989404000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1880745000.0,"operatingIncome":-2857890000.0,"nonOperatingIncome":39216000.0,"nonOperatingExpenses":332030000.0,"interestExpense":null,"ordinaryProfit":-3150703000.0,"extraordinaryGain":5418000.0,"extraordinaryLoss":21123000.0,"incomeBeforeTax":-3166409000.0,"incomeTaxes":8320000.0,"netIncome":-3174729000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-3174729000.0,"comprehensiveIncome":-3248142000.0,"eps":-27.08,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/11\/12","stockCode":4563,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":90.0,"averageTemporaryStaff":5.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":13927661.0,"sharesOwendPercent":0.1046,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":244.53,"equityRatio":0.848,"cashAndCashEquivalents":11537028000.0,"assets":38354611000.0,"currentAssets":14166633000.0,"fixedAsset":24187977000.0,"tangibleFixedAssets":236098000.0,"intangibleFixedAssets":22713938000.0,"investmentAndOtherAssets":1237940000.0,"liabilities":5674936000.0,"currentLiabilities":5589864000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":85072000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":32679675000.0,"capitalStock":32724444000.0,"capital":24612076000.0,"capitalSurplus":22756406000.0,"accumulatedEarnings":-14644009000.0,"treasuryStock":-30000.0,"valuationAndConversionAdjustments":-187277000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":23020000.0,"grossProfit":null,"sgaExpenses":1820230000.0,"salaryAndBenefit":160748000.0,"depreciationAndSGA":3878000.0,"RDExpenses":3796139000.0,"operatingIncome":-5599392000.0,"nonOperatingIncome":24572000.0,"nonOperatingExpenses":1043533000.0,"interestExpense":12344000.0,"ordinaryProfit":-6618353000.0,"extraordinaryGain":2433625000.0,"extraordinaryLoss":20222000.0,"incomeBeforeTax":-4204950000.0,"incomeTaxes":4560000.0,"netIncome":-4209511000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-4209511000.0,"comprehensiveIncome":-4395299000.0,"eps":-35.33,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-2961329000.0,"depreciationAndCashflowFromOperatingActivities":7585000.0,"cashFlowFromInvestingActivities":-6963969000.0,"cashFlowFromFinancialActivities":11403576000.0,"changesInCashAndCashEquivalents":1496433000.0,"列1":"asr","submitDate":"2021\/3\/31","stockCode":4563,"accountingYear":"第22期(自? 2020年１月１日? 至? 2020年12月31日)","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.862,"cashAndCashEquivalents":null,"assets":42261792000.0,"currentAssets":17318333000.0,"fixedAsset":24943458000.0,"tangibleFixedAssets":122843000.0,"intangibleFixedAssets":23549628000.0,"investmentAndOtherAssets":1270986000.0,"liabilities":5697502000.0,"currentLiabilities":5621015000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":76486000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":36564289000.0,"capitalStock":35211077000.0,"capital":27512512000.0,"capitalSurplus":25656842000.0,"accumulatedEarnings":-17958247000.0,"treasuryStock":-31000.0,"valuationAndConversionAdjustments":1199068000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":6906000.0,"grossProfit":null,"sgaExpenses":1216691000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2416248000.0,"operatingIncome":-3628302000.0,"nonOperatingIncome":302353000.0,"nonOperatingExpenses":35437000.0,"interestExpense":65000.0,"ordinaryProfit":-3361386000.0,"extraordinaryGain":32844000.0,"extraordinaryLoss":null,"incomeBeforeTax":-3328542000.0,"incomeTaxes":-14304000.0,"netIncome":-3314238000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-3314238000.0,"comprehensiveIncome":-1927892000.0,"eps":-24.82,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/5\/14","stockCode":4563,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":11824153.0,"sharesOwendPercent":0.0772,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.849,"cashAndCashEquivalents":23752821000.0,"assets":51758205000.0,"currentAssets":27489041000.0,"fixedAsset":24269163000.0,"tangibleFixedAssets":120553000.0,"intangibleFixedAssets":23017787000.0,"investmentAndOtherAssets":1130822000.0,"liabilities":7709343000.0,"currentLiabilities":7634341000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":75001000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":44048862000.0,"capitalStock":42793031000.0,"capital":33359568000.0,"capitalSurplus":15643407000.0,"accumulatedEarnings":-6209913000.0,"treasuryStock":-31000.0,"valuationAndConversionAdjustments":1154719000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":13812000.0,"grossProfit":null,"sgaExpenses":2588224000.0,"salaryAndBenefit":115590000.0,"depreciationAndSGA":1899000.0,"RDExpenses":4961917000.0,"operatingIncome":-7540867000.0,"nonOperatingIncome":294017000.0,"nonOperatingExpenses":83989000.0,"interestExpense":45000.0,"ordinaryProfit":-7330839000.0,"extraordinaryGain":32844000.0,"extraordinaryLoss":138587000.0,"incomeBeforeTax":-7436583000.0,"incomeTaxes":13442000.0,"netIncome":-7450026000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-7450026000.0,"comprehensiveIncome":-6108029000.0,"eps":-52.7,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-5298747000.0,"depreciationAndCashflowFromOperatingActivities":8096000.0,"cashFlowFromInvestingActivities":-76455000.0,"cashFlowFromFinancialActivities":17393182000.0,"changesInCashAndCashEquivalents":12215793000.0,"列1":"q2r","submitDate":"2021\/8\/13","stockCode":4563,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0},{"edinetCode":"E05301","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.832,"cashAndCashEquivalents":null,"assets":47735595000.0,"currentAssets":23723218000.0,"fixedAsset":24012376000.0,"tangibleFixedAssets":187167000.0,"intangibleFixedAssets":22683570000.0,"investmentAndOtherAssets":1141639000.0,"liabilities":7921757000.0,"currentLiabilities":7827652000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":94105000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":39813837000.0,"capitalStock":38290148000.0,"capital":33359568000.0,"capitalSurplus":15643407000.0,"accumulatedEarnings":-10712796000.0,"treasuryStock":-31000.0,"valuationAndConversionAdjustments":1406403000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":39392000.0,"grossProfit":null,"sgaExpenses":3678017000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":8490503000.0,"operatingIncome":-12163392000.0,"nonOperatingIncome":437552000.0,"nonOperatingExpenses":97939000.0,"interestExpense":null,"ordinaryProfit":-11823779000.0,"extraordinaryGain":32844000.0,"extraordinaryLoss":163203000.0,"incomeBeforeTax":-11954138000.0,"incomeTaxes":-1229000.0,"netIncome":-11952909000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-11952909000.0,"comprehensiveIncome":-10359228000.0,"eps":-82.25,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/11\/12","stockCode":4563,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E05301","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5367,"settlementDate":"2022\/12\/31","submitterName":"アンジェス株式会社","submitterNameEnglish":"AnGes, Inc.","submitterNameKana":"アンジェス　カブシキガイシャ","location":"茨木市彩都あさぎ七丁目７番１５号","industory":"医薬品","corporateNumber":6120000000000.0}]